Biotech companies in the United States by today's price change
How far the share price has moved since the previous close.
Scholar Rock Holding leads the 20 biotech companies in the United States ranked by today's price change, at +4.94%, ahead of CG Oncology (+2.38%) and Moderna (+1.29%). Figures as of 20 Nov 2026, 13:57 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Scholar Rock Holding+4.94%
- Median
- -1.41%
- Combined market value
- NOK 7.16T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Scholar Rock HoldingSRRK · Health Care | +4.94% | NOK 59.9B | NOK 490.68 | 4.94% up | 25% up | ||
| 2 | CG OncologyCGON · Health Care | +2.38% | NOK 71.3B | NOK 797.84 | 2.38% up | 93% up | ||
| 3 | ModernaMRNA · Health Care | +1.29% | NOK 785.7B | NOK 1,941.79 | 1.29% up | 740% up | ||
| 4 | Krystal BiotechKRYS · Health Care | +0.15% | NOK 91.2B | NOK 3,076.59 | 0.15% up | 49% up | ||
| 5 | Kodiak SciencesKOD · Health Care | +0.09% | NOK 62.4B | NOK 953.70 | 0.09% up | 371% up | ||
| 6 | Bio-TechneTECH · Health Care | -0.07% | NOK 111.3B | NOK 708.21 | 0.07% down | 18% up | ||
| 7 | Revolution MedicinesRVMD · Health Care | -0.24% | NOK 335.9B | NOK 1,553.10 | 0.24% down | 125% up | ||
| 8 | VaxcytePCVX · Health Care | -0.27% | NOK 90B | NOK 568.52 | 0.27% down | 22% up | ||
| 9 | AmgenAMGN · Health Care | -1.14% | NOK 2.31T | NOK 4,274.81 | 1.14% down | 30% up | ||
| 10 | RepligenRGEN · Health Care | -1.38% | NOK 106B | NOK 1,658.90 | 1.38% down | 5% up | ||
| 11 | Kymera TherapeuticsKYMR · Health Care | -1.44% | NOK 99.3B | NOK 1,163.05 | 1.44% down | 81% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | -1.44% | NOK 44.2B | NOK 273.25 | 1.44% down | 51% up | ||
| 13 | Gilead SciencesGILD · Health Care | -1.45% | NOK 2.01T | NOK 1,622.27 | 1.45% down | 31% up | ||
| 14 | BiogenBIIB · Health Care | -1.70% | NOK 355.9B | NOK 2,407.44 | 1.70% down | 41% up | ||
| 15 | ImmunityBioIBRX · Health Care | -1.94% | NOK 68.1B | NOK 64.00 | 1.94% down | 216% up | ||
| 16 | ImmunovantIMVT · Health Care | -1.96% | NOK 65.6B | NOK 316.80 | 1.96% down | 44% up | ||
| 17 | Halozyme TherapeuticsHALO · Health Care | -2.88% | NOK 103.3B | NOK 906.36 | 2.88% down | 32% up | ||
| 18 | ExelixisEXEL · Health Care | -3.60% | NOK 156.5B | NOK 641.29 | 3.60% down | 55% up | ||
| 19 | Neurocrine BiosciencesNBIX · Health Care | -3.85% | NOK 154.4B | NOK 1,525.44 | 3.85% down | 10% up | ||
| 20 | Twist BioscienceTWST · Health Care | -4.07% | NOK 74.1B | NOK 1,087.36 | 4.07% down | 291% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7416 NOK).
Questions and answers
Which biotech companies in the United States rank first by today's price change?
Scholar Rock Holding (+4.94%), CG Oncology (+2.38%) and Moderna (+1.29%) are the top three of the 20 biotech companies in the United States ranked by today's price change as of 20 Nov 2026, 13:57 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by today's price change.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by today's price change have a combined market value of NOK 7.16T as of 20 Nov 2026, 13:57 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech companies in the United States by today's price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.